Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ilaprazole vs esomeprazole for non-variceal upper gastrointestinal bleeding without endoscopic hemostasis
ChiCTR2100054544Phase 4Completed
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ilaprazole in upper gastrointestinal bleeding (UGIB) (2 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoint: Clinical hemostasis rate on day 3. Started Aug 2019; status: completed.
02
Drugs
ilaprazole
03
Conditions
upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on ChiCTR2100054544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054544.